Ashurst is advising Bioquell plc,  provider of specialist microbiological control technologies to the international Healthcare, Life Science and Defence markets, on its disposal of its specialist testing services subsidiary, TRaC, to Element Materials Technology Group Holdings Limited for a cash consideration of £44.5 million.

The Ashurst team was led by corporate partners Richard Gubbins and Karen Davies, assisted by associate Marianna Kennedy, solicitors Andrew Mclaren, Hayley Gow and Shari Taylor and trainee Nick Lever. The team also comprised partner Richard Palmer and senior associate Philippa Michie (Tax), counsel Stephen Diosi (Options), senior associate Andy Wright (Pensions), solicitor Dominic Boon (Employment), consultant Andy Waite (Environment) and senior associate Mark Sweny (IT/IP).